eLaws | eCases | United States Code | Federal Courts |

Anonymous - Comment

Document ID: FDA-2011-D-0597-0004
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: September 08 2011, at 12:00 AM Eastern Daylight Time
Date Posted: September 29 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: August 29 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: November 28 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f144e0
View Document:

This is comment on Notice

Draft Guidance for Industry; Availability: Oversight of Clinical Investigations; A Risk-Based Approach to Monitoring

View Comment

This is a well thought out document and is helpful in clarifying the regulation.

Related Comments

View All

Total: 34

Anonymous - Comment
Public Submission Posted: 09/29/2011 ID: FDA-2011-D-0597-0004

Comment Period Closed
Nov 28,2011 11:59 PM ET

Janet Athene Lane - Comment
Public Submission Posted: 11/14/2011 ID: FDA-2011-D-0597-0008

Comment Period Closed
Nov 28,2011 11:59 PM ET

Cheryl Elaine Kelly - Comment
Public Submission Posted: 11/14/2011 ID: FDA-2011-D-0597-0011

Comment Period Closed
Nov 28,2011 11:59 PM ET

Wayne Martin - Comment
Public Submission Posted: 11/14/2011 ID: FDA-2011-D-0597-0014

Comment Period Closed
Nov 28,2011 11:59 PM ET

Bausch+Lomb - Comment
Public Submission Posted: 12/05/2011 ID: FDA-2011-D-0597-0016

Comment Period Closed
Nov 28,2011 11:59 PM ET